Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Zomedica Pharmaceuticals (ZOM)
:ZOM
ZOM Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.12 - $0.20
Previous CloseN/A
Volume6.59M
Average Volume (3M)3.91M
Market Cap
$117.79M
Enterprise Value$59.65M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.08
Next Earnings
Mar 04, 2025EPS Estimate
>-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.06
Shares Outstanding979,949,650
10 Day Avg. Volume3,227,033
30 Day Avg. Volume3,907,657
Standard Deviation0.48
R-Squared0.01
Alpha0.04
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)4.41
Price to Cash Flow (P/CF)-6.20
P/FCF Ratio0.00
Enterprise Value/Market Cap0.51
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit3.44
Enterprise Value/Ebitda-1.10
Forecast
1Y Price Target
$0.25Price Target Upside108.33% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
---
Zomedica Pharmaceuticals News
PremiumCompany Announcements
Zomedica Appoints New CFO to Drive Growth
PremiumCompany Announcements
Zomedica’s Revenue Up 10% Amid Global Expansion
PremiumCompany Announcements
Zomedica Corp Posts Increased Revenue Amid Loss
PremiumCompany Announcements
Zomedica Achieves Record Revenue and Steady Growth in 2023---
Ownership Overview
1.74% Insiders
5.84% Mutual Funds
0.48% Other Institutional Investors
87.21% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
ZOM FAQ
What was Zomedica Pharmaceuticals’s price range in the past 12 months?
Zomedica Pharmaceuticals lowest stock price was $0.12 and its highest was $0.20 in the past 12 months.
What is Zomedica Pharmaceuticals’s market cap?
Zomedica Pharmaceuticals’s market cap is $117.79M.
When is Zomedica Pharmaceuticals’s upcoming earnings report date?
Zomedica Pharmaceuticals’s upcoming earnings report date is Mar 04, 2025 which is in 10 days.
How were Zomedica Pharmaceuticals’s earnings last quarter?
Zomedica Pharmaceuticals released its earnings results on Nov 07, 2024. The company reported -$0.01 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.01.
Is Zomedica Pharmaceuticals overvalued?
According to Wall Street analysts Zomedica Pharmaceuticals’s price is currently Undervalued.
Does Zomedica Pharmaceuticals pay dividends?
Zomedica Pharmaceuticals does not currently pay dividends.
What is Zomedica Pharmaceuticals’s EPS estimate?
Zomedica Pharmaceuticals’s EPS estimate is >-0.01.
How many shares outstanding does Zomedica Pharmaceuticals have?
Zomedica Pharmaceuticals has 979,949,650 shares outstanding.
What happened to Zomedica Pharmaceuticals’s price movement after its last earnings report?
Zomedica Pharmaceuticals reported an EPS of -$0.01 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Zomedica Pharmaceuticals?
Currently, no hedge funds are holding shares in ZOM
---
Zomedica Pharmaceuticals Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$0.25 (108.33% Upside)
$0.25 (108.33% Upside)
Blogger Sentiment
Bullish
ZOM Sentiment 100%
Sector Average 70%
Sector Average 70%
Insider Transactions
Bought Shares
Worth $18.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days <0.1%
Last 30 Days ▲ 0.5%
Last 30 Days ▲ 0.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-7.69%
12-Months-Change
Fundamentals
Return on Equity
-26.82%
Trailing 12-Months
Asset Growth
-22.15%
Trailing 12-Months
Company Description
Zomedica Pharmaceuticals
Zomedica Pharmaceuticals Corp. operates as a development stage veterinary diagnostic and pharmaceutical company. It creates products for companion animals by focusing on the unmet needs of clinical veterinarians. The company was founded by Gerald L. Solensky, Jr. on January 7, 2013 and is headquartered in Ann Arbor, MI.
---
ZOM Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflected strong revenue growth and successful global expansion initiatives, with improvements in cost management and financial health. However, the increased net loss, challenges in Assisi sales, and potential delisting risk present concerns moving forward.Read More>---
ZOM Stock 12 Month Forecast
Average Price Target
$0.25
▲(108.33% Upside)
Technical Analysis
Idexx Laboratories
―
Petmed Express
―
Zoetis
―
Hepion Pharmaceuticals
―
Elanco Animal Health
―
Best Analysts Covering ZOM
1 Year
1 Year Success Rate
0/2 ratings generated profit
1 Year Average Return
-1.60%
reiterated a buy rating 16 days ago
Copying Robert LeBoyer's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -1.60% per trade.
---